Physician profile
Robert Ziffra
NPI 1407588783
$3,029.03
in general payments reported to CMS, 2019-2025
17 companies · $836 in 2025
The $836 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $321 · 2023: $1,073 · 2024: $799 · 2025: $836.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,708.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,707.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $560.45 | 2022-2025 | Motoband, Minibunion, Na |
| Smith+Nephew, INC. | $377.64 | 2023-2024 | Stravix, Grafix Pl, Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Treace Medical Concepts, INC. | $376.65 | 2024-2025 | |
| Stryker Corporation | $367.45 | 2023-2025 | Augment Injectable, Ortholoc 2 Lapifuse, Hoffmann |
| Linvatec Corporation | $269.32 | 2025 | Biobrace 23mm, Neospan, Ibs |
| Medline Industries LP | $165.23 | 2023 | |
| Innovation Technologies INC | $148.18 | 2023 | Irrisept |
| Integra Lifesciences Corporation | $147.67 | 2022 | |
| Cardiovascular Systems INC. | $132.37 | 2023 | Diamondback Peripheral |
| Paratek Pharmaceuticals, INC. | $121.80 | 2024 | Nuzyra |
| Polynovo North America LLC | $121.73 | 2024 | Novosorb Btm |
| Orthofix Medical, INC. | $67.42 | 2023-2024 | Physio-Stim |
| Medshape, INC. | $49.36 | 2023-2024 | Dynanail |
| Kerecis Limited | $48.28 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Reprise Biomedical, INC. | $33.87 | 2023 | Miro3d |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $23.85 | 2022 | |
| Lightbody Medical Technologies INC | $17.76 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Ziffra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.